Biblio Discovery — Demo Discovery Service

14 results for "Anthony P. Conley"

Showing 1–14 · 0.73 seconds · RSS

  1. Journal Article Full text

    A tool for discovering drug sensitivity and gene expression associations in cancer cells.

    Yong Qin; Anthony P Conley; Elizabeth A Grimm et al.

    PLoS ONE, Vol. 12 No. 4 · 2017 · English · DOAJ Scopus

    The sensitivity of cancer cells to anticancer drugs is a crucial factor for developing effective treatments. However, it is still challenging to precisely predict the effectiveness of therapeutics in humans within a complex genomic and molecular context. We developed an interface which allows the…

    Also available at: PLOS

  2. Journal Article

    Disseminated Coccidioidomycosis Following COVID-19 Mimicking Metastatic Thoracic Relapse of Well-Differentiated Liposarcoma: A Case Report

    Elise F. Nassif; Nolan Maloney; Anthony P. Conley et al.

    Frontiers in Medicine, Vol. 8 · 2021 · English · DOAJ Scopus

    Introduction: COVID-19 is associated with immune dysregulation which may increase susceptibility to atypical infectious diseases, particularly in the vulnerable cancer patient population. Coccidioidomycosis is an endemic fungal infection which presents with mild-to-moderate pneumonia in most…

  3. Journal Article Full text

    Molecular Imaging with 3′-deoxy-3′[(18)F]-Fluorothymidine (18F-FLT) PET/CT for Early Response to Targeted Therapies in Sarcomas: A Pilot Study

    Kalevi Kairemo; Elmer B. Santos; Homer A. Macapinlac et al.

    Diagnostics, Vol. 10 No. 3 · 2020 · English · DOAJ Scopus

    Although 3′-deoxy-3′[(18)F]-fluorothymidine (FLT)-positron emission tomography (PET) has been utilized for tumor response assessment to neoadjuvant chemotherapy in soft tissue sarcomas, it has not been exploited for the assessment of early response to systematically targeted therapies. Herein, we…

  4. Journal Article

    Guillain-Barre syndrome observed with adoptive transfer of lymphocytes genetically engineered with an NY-ESO-1 reactive T-cell receptor

    Jocelyn Joseph; Michael J. Nathenson; Van Anh Trinh et al.

    Journal for ImmunoTherapy of Cancer, Vol. 7 No. 1 · 2019 · English · DOAJ Scopus

    Abstract Background Adoptive transfer of autologous T-lymphocytes transduced with a high affinity NY-ESO-1-reactive T-cell receptor (NY-ESO-1c259 T-cells) has emerged as a promising therapeutic strategy for patients with refractory synovial sarcoma. Secondary autoimmune T-cell mediated toxicities…

  5. Journal Article

    Prognostic molecular biomarkers in chordomas: A systematic review and identification of clinically usable biomarker panels

    Franco Rubino; Christopher Alvarez-Breckenridge; Kadir Akdemir et al.

    Frontiers in Oncology, Vol. 12 · 2022 · English · DOAJ Scopus

    Introduction and objectiveDespite the improvements in management and treatment of chordomas over time, the risk of disease recurrence remains high. Consequently, there is a push to develop effective systemic therapeutics for newly diagnosed and recurrent disease. In order to tailor treatment for…

  6. Journal Article

    Case Report: Complete response to the concurrent neoadjuvant radiation therapy and pembrolizumab in a locally recurrent, chemotherapy-refractory undifferentiated pleomorphic sarcoma of bone

    Brina A. Patel; Jason T. Smith; Sintawat Wangsiricharoen et al.

    Frontiers in Oncology, Vol. 16 · 2026 · English · DOAJ Scopus

    Undifferentiated pleomorphic sarcoma of bone (UPS-B) is a rare and aggressive cancer that accounts for a small fraction of bone sarcomas. Compared to both undifferentiated pleomorphic sarcoma of soft tissue (UPS-ST) and osteosarcoma, UPS-B demonstrates lower chemosensitivity and a poorer prognosis…

  7. Journal Article

    Clinical characteristics and outcomes of adult alveolar rhabdomyosarcoma patients on first-line systemic therapies: A single-institution cohort

    Michael S Nakazawa; J Andrew Livingston; Maria A Zarzour et al.

    Rare Tumors, Vol. 16 · 2024 · English · DOAJ Scopus

    Background: Rhabdomyosarcomas are the most common soft tissue sarcoma in children, and pediatric alveolar rhabdomyosarcoma (ARMS) prognosis has improved based on cooperative studies. However, in adults, ARMS is significantly rarer, has poorer outcomes, and currently lacks optimal treatment…

  8. Journal Article

    Retrospective evaluation of the role of gemcitabine‐docetaxel in well‐differentiated and dedifferentiated liposarcoma

    Prapassorn Thirasastr; Heather Lin; Behrang Amini et al.

    Cancer Medicine, Vol. 12 No. 4 · 2023 · English · DOAJ Scopus

    Abstract Objective Well‐differentiated (WDLPS) and dedifferentiated liposarcoma (DDLPS) account for the majority of liposarcomas. Although gemcitabine‐docetaxel is used as second‐line treatment in soft tissue sarcomas, its efficacy in WDLPS/DDLPS is not established. This study retrospectively…

  9. Journal Article

    Hypofractionated Radiation Therapy for Unresectable or Metastatic Sarcoma Lesions

    David Boyce-Fappiano, MD, MHM; Ethan P. Damron, BS; Ahsan Farooqi, MD, PhD et al.

    Advances in Radiation Oncology, Vol. 7 No. 3 · 2022 · English · DOAJ Scopus

    Purpose: Given the relative radioresistance of sarcomas and their often large size, conventional palliative radiation therapy (RT) often offers limited tumor control and symptom relief. We report on our use of hypofractionated RT (HFRT) as a strategy to promote durable local disease control and…

  10. Journal Article

    Immuno-genomic landscape of osteosarcoma

    Chia-Chin Wu; Hannah C. Beird; J. Andrew Livingston et al.

    Nature Communications, Vol. 11 No. 1 · 2020 · English · DOAJ Scopus

    The efficacy of immune checkpoint inhibitors (ICI) in osteosarcoma has been limited. Here, the authors investigate the immunogenomic landscape of osteosarcoma, and integrated analyses highlight features related to a suppressed immune microenvironment.

  11. Journal Article

    Pilot study of bempegaldesleukin in combination with nivolumab in patients with metastatic sarcoma

    Sandra P. D’Angelo; Allison L. Richards; Anthony P. Conley et al.

    Nature Communications, Vol. 13 No. 1 · 2022 · English · DOAJ Scopus

    The activity of PD-1 blockade in patients with sarcoma has been modest so far. Here, the authors report the results of a pilot clinical trial to assess the efficacy and safety of bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, in combination with the PD1 blockade…

  12. Journal Article

    The immune landscape of undifferentiated pleomorphic sarcoma

    Rossana Lazcano; Carmelia M. Barreto; Ruth Salazar et al.

    Frontiers in Oncology, Vol. 12 · 2022 · English · DOAJ Scopus

    IntroductionUndifferentiated pleomorphic sarcoma (UPS) can be associated with a relatively dense immune infiltration. Immune checkpoint inhibitors (anti-PD1, anti-PDL1, and anti-CTLA4) are effective in 20% of UPS patients. We characterize the immune microenvironment of UPS and its association with…